Vassilios Kosmas
Analyst · Morgan Stanley
Thank you, Vassili. Hello from my end as well. Let's start with the P&L on Slide 6, please. Reported profit for the quarter was EUR 269 million. Just to refresh your memory, Q2 was positively affected by a large one-off recognition of deferred tax asset. So that explains much of the headline. On a normalized basis, profit stood at EUR 283 million and are up 3% quarter-on-quarter. In terms of one-off items, evidently not much to report this quarter. There's a small EUR 5 million donation to the Greek University refurbishment program and then some bits and pieces for Katseli law and CHF loans perimeters, where the impacts have been finalized. In particular, with CHF loans, we had a EUR 20 million perimeter where we took an impact of 20% already fully provided. And now we have a remaining EUR 55 million position with a provision coverage circa 30%. The EUR 25 million impact from the donation of school renovations, the so-called Marietta Giannakou program will likely come in Q4. With that, let's move to the next slide and look at the underlying results. Operating income increased 1% quarter-on-quarter. Both net interest income and fees grew at a solid pace. Trading and other income was somewhat lower than our expectations. This is not due to lower client activity by the usual lower summer seasonality vis-a-vis brokerage but instead, it should be attributed to our ALM portfolio management, where we continuously assess opportunities to recycle the securities book against the value of retaining attractive carry. This quarter, the economics favor carry over crystallizing gain. On costs, again, we had a particularly good quarter. Cost to income stood at just 36% for Q3 with the move versus last quarter, mainly attributable to the second quarter bonus expense. We'll talk about guidance at the end. But just as a note, we do expect seasonal upswing in Q4. Another good quarter for provisions, despite the overall external macro uncertainties, this has not yet surfaced in our loan book in any material manner. Turning to the balance sheet. A fairly strong Q3 for loans with EUR 400 million of net credit expansion and the book up 1% versus Q2. We remain very much on track to reach our full year guidance. So as a reminder, that would require circa EUR 600 million of net credit expansion in Q4. For customer funds, we have had good growth in the quarter with some headwinds from our Greek custodian portfolio valuation effects. This did not have and will not have any meaningful impact on our asset management fees. Tangible book value, up 5% in the quarter and 11% year-on-year when adjusting for distributions. And then on capital, our CET1 ratio stands at 14.5%, up 20 basis points versus Q2. Slide 9 for the 2 main components of revenues. Net interest income up by an exceptional 8% in the quarter, circa EUR 5 million attributable to the extra calendar day that we have in Q3. A good part of the uplift comes from the lower securities volumes on account of the growth we had during previous as well as this quarter. Another part came from higher deposit volumes, mainly on the corporate side. That has an impact on the mix and thus, the average cost. However, as you can see later in the presentation, the overall beta of our Greek deposit book hasn't much changed. The reason is that we have benefited on the retail side from the mismatch between sharp increase in rates and longer duration of retail time deposits. All in, we're seeing the cumulative impact of 2 separate things here. Number one, higher volumes of loans, securities and deposits and overall, having a positive impact on our NII. Number two, even though our sensitivity to changes in rates has not much changed, the way it propagates through the balance sheet, given the pace at which rates have come up, means that we're seeing a bigger benefit to start with. This benefit would fade away as time goes by and retail time deposits revert to more normal levels of pass-through. Bottom line, good news for NII overall with some better news in the near term. Switching to fees and more straightforward story and a strong quarter overall. Asset Management reverting to a solid trend and a record quarter, crossing the EUR 40 million mark. Softer quarter naturally for investment banking and business credit-related fees as activity has softened after a very strong start to the year. Last but not least, with no dividend from Prodea this quarter, I think it's the first time we're seeing the underlying revenue generation from the real estate book in a very clear manner. Moving on to Slide 10 to look at loan and customer funds. Performing loan balance is now past the EUR 40 billion mark, up 1% in the quarter. EUR 400 million in net credit expansion. Naturally, a slower quarter for disbursements at EUR 2.8 billion, given a quiet summer season, with repayments also abated to EUR 2.5 billion following a strong second quarter. Q3 was a more interesting quarter for customer funds. Deposit growth this quarter, mainly coming from corporate deposits. There is an element of seasonality in this, but in earnest, we seem to be outperforming our expectations on this front. On AUMs, another strong quarter for net sales, EUR 400 million, taking the year-to-date figure to EUR 1.1 billion, just above the guidance for the year. And then given the market volatility, we've seen a significant EUR 1.4 billion negative valuation effects that relates to equities under custody. So not really impacting our recurring business. Turning to Slide 11 on asset quality. NPE ratio came in at 3.8%. The small increase in the stock of NPEs coming from 2 items. One is a large European corporate syndication that has been restructured and provisioned in our part. So we would expect to cure in a relatively straightforward way. And then as in previous quarters, we're nearing the end of the process with regards to re-profiling mortgages. So that has had a small incremental impact this quarter. Coverage ratio edging down to 52%, mainly as a result of the low-risk nature of the exposures, flowing into NPE perimeter. And that is also reflected in the underlying cost of risk, which stood at 32 basis points this quarter. Overall, the picture looks okay despite jitters in the market. Then on Slide 12, on capital to wrap it up. All-in, CET1 ratio stands at 14.5% on a transitional basis. 124 basis points of organic capital generation in the first 9 months of the year. As we highlighted during the last results call, we have seen a positive impact from the new synthetic securitization this quarter, increasing CET1 by 17 basis points versus Q2. No impact from the volatility in the bond markets as our securities book is predominantly booked at amortized cost. Our fair value through OCI book accounts for just 7% of our total book and that produces very low capital volatility. And then we also have the payout accrual at 55% of reported profit with DTC acceleration coming on top. This translates into circa EUR 420 million accrued towards distributions so far this year. And we intend to distribute circa EUR 124 million as an interim cash dividend in early December. Lastly, from my side, an update for the guidance for the year. Let's take things one by one. I think we should be clear that we're outperforming our guidance on NII. As a result, we now expect EUR 1.8 billion net interest income in 2026. Our guidance on fees is unchanged at above EUR 600 million. As a reminder, that excludes the EUR 40 million benefit we had in Q2 from Prodea. So the figure we will post will be closer to EUR 640 million. We're not changing the guidance on other revenue. So the EUR 50 million upgrade to NII translates to total revenue guidance up to EUR 2.5 billion. On costs, no change. We still expect to land at EUR 960 million for the year. So as discussed, there will be a seasonal step-up in Q4. As a result of the uncertainty in the macroeconomic environment, we will reexamine our models of Q4 as is customary. Hence, there is a chance that our cost of risk for the year will land above 45 basis points. There's no real change to the rest of the line. So our full year guidance of EUR 950 million in reported profit is reiterated and so is our guidance for EUR 0.41 of EPS. Just a health warning before we jump into Q&A, given we have Investor Day in less than a week, we will refrain from providing any further guidance on the outlook near term or longer term. With that, let's now open the floor for questions.